Patents by Inventor Sander DE WILDE

Sander DE WILDE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for preparing 5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]-methyl]-2,4-thiazolidinedione and salts thereof
    Patent number: 11731963
    Abstract: The disclosure provides a process of making the compound of Formula I, and pharmaceutically acceptable salts thereof; and the process of making the intermediate of Formula III; wherein PG is as defined as set forth in the specification.
    Type: Grant
    Filed: September 20, 2021
    Date of Patent: August 22, 2023
    Assignee: Minoryx Therapeutics S.L.
    Inventors: Ana Maria García Collazo, Wolter Ten Hoeve, Johannes Nicolaas Koek, Johannes B. M. Rewinkel, Sander De Wilde
  • PROCESS FOR PREPARING 5-[[4-[2-[5-(1-HYDROXYETHYL)-2-PYRIDINYL]ETHOXY]PHENYL]-METHYL]-2,4-THIAZOLIDINEDIONE AND SALTS THEREOF
    Publication number: 20220204496
    Abstract: The disclosure provides a process of making the compound of Formula I, and pharmaceutically acceptable salts thereof; and the process of making the intermediate of Formula III; wherein PG is as defined as set forth in the specification.
    Type: Application
    Filed: September 20, 2021
    Publication date: June 30, 2022
    Applicant: Minoryx Therapeutics S.L.
    Inventors: Ana Maria GARCÍA COLLAZO, Wolter TEN HOEVE, Johannes Nicolaas KOEK, Johannes B.M. REWINKEL, Sander DE WILDE
  • Process for preparing 5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]methyl]-2,4-thiazolidinedione and salts thereof
    Patent number: 11124505
    Abstract: The disclosure provides a process of making the compound of Formula I, and pharmaceutically acceptable salts thereof: and the process of making the intermediate of Formula III: wherein PG is as defined as set forth in the specification.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: September 21, 2021
    Assignee: Minoryx Therapeutics S.L.
    Inventors: Ana Maria García Collazo, Wolter Ten Hoeve, Johannes Nicolaas Koek, Johannes B. M. Rewinkel, Sander De Wilde
  • PROCESS FOR PREPARING 5-[[4-[2-[5-(1-HYDROXYETHYL)-2-PYRIDINYL]ETHOXY]PHENYL]METHYL]-2,4-THIAZOLIDINEDIONE AND SALTS THEREOF
    Publication number: 20190389852
    Abstract: The disclosure provides a process of making the compound of Formula I, and pharmaceutically acceptable salts thereof: and the process of making the intermediate of Formula III: wherein PG is as defined as set forth in the specification.
    Type: Application
    Filed: December 22, 2017
    Publication date: December 26, 2019
    Applicant: Minoryx Therapeutics S.L.
    Inventors: Ana Maria GARCÍA COLLAZO, WoIter TEN HOEVE, Johannes Nicolaas KOEK, Johannes B.M. REWINKEL, Sander DE WILDE